Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paola Camargo-Mamani"'
Autor:
Macarena Hernández-Jiménez, Samuel Martín-Vílchez, Dolores Ochoa, Gina Mejía-Abril, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Bernd Jilma, María A. Moro, Gerónimo Fernández, David Piñeiro, Marc Ribó, Víctor M. González, Ignacio Lizasoain, Francisco Abad-Santos
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 28, Iss , Pp 124-135 (2022)
ApTOLL is an aptamer that antagonizes Toll-like receptor 4 and improves functional outcomes in models of ischemic stroke and myocardial infarction. The aim of this study was to characterize the safety and pharmacokinetics of ApTOLL in healthy volunte
Externí odkaz:
https://doaj.org/article/1d6415b299c844c7bc5d3c6a71847c5b
Autor:
Manuel Román Martinez, Eva García Aguilar, Samuel Martin Vílchez, Javier González García, Sergio Luquero-Bueno, Paola Camargo-Mamani, Gina Mejia-Abril, Laura García-Castro, Alejandro de Miguel-Cáceres, Paula Saz-Leal, Francisco Abad-Santos, Concepcion Nieto Magro, Dolores Ochoa Mazarro
Background: Melatonin is an endogenous substance which plays a key role in sleep induction by reducing sleep onset latency; it has been approved by the European Food Safety Authority as a food supplement for exogenous administration. Oniria® is a fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7330ba47c74aba1023261c44304ff71e
https://doi.org/10.1007/s40268-022-00394-3
https://doi.org/10.1007/s40268-022-00394-3
Autor:
Manuel, Román Martinez, Eva, García Aguilar, Samuel, Martin Vílchez, Javier, González García, Sergio, Luquero-Bueno, Paola, Camargo-Mamani, Gina, Mejia-Abril, Laura, García-Castro, Alejandro, de Miguel-Cáceres, Paula, Saz-Leal, Francisco, Abad-Santos, Concepcion, Nieto Magro, Dolores, Ochoa Mazarro
Publikováno v:
Drugs in RD. 22(3)
Melatonin is an endogenous substance which plays a key role in sleep induction by reducing sleep onset latency; it has been approved by the European Food Safety Authority as a food supplement for exogenous administration. OniriaThe main objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::780760893962ae98d93f048dde516df7
https://pubmed.ncbi.nlm.nih.gov/35918587
https://pubmed.ncbi.nlm.nih.gov/35918587
Autor:
Miriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 3; Pages: 489
For patients with type 2 diabetes, metformin is the most often recommended drug. However, there are substantial individual differences in the pharmacological response to metformin. To investigate the effect of transporter polymorphisms on metformin p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c773fe5245e892c44dd13fe63344b6f
https://doi.org/10.3390/jpm13030489
https://doi.org/10.3390/jpm13030489